Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction
- PMID: 25756844
- DOI: 10.1002/ejhf.211
Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction
Abstract
Aims: To investigate the prognostic significance of hospitalization for worsening heart failure (WHF), myocardial infarction (MI), and stroke in patients with chronic heart failure (HF).
Methods and results: We studied 5011 patients with HF and reduced EF (HF-REF) in the CORONA trial and 4128 patients with HF and preserved EF (HF-PEF) in the I-Preserve trial. Adjusted hazard ratios (HRs) for death were estimated for 0-30 days and ≥31 days after first post-randomization WHF, MI, or stroke used as a time-dependent variable, compared with patients with none of these events. In CORONA, 1616 patients (32%) had post-randomization first events (1223 WHF, 216 MI, 177 stroke), and the adjusted HR for mortality ≤30 days after an event was: WHF 7.21 [95% confidence interval (CI) 2.05-25.40], MI 23.08 (95% CI 6.44-82.71), and stroke 32.15 (95% CI 8.93-115.83). The HR for mortality at >30 days was: WHF 3.62 (95% CI 3.11-4.21), MI 4.41 (95% CI 3.23-6.02), and stroke 3.19 (95% CI 2.21-4.61). In I-Preserve, 896 patients (22%) experienced a post-randomization event (638 WHF, 111 MI, 147 stroke). The HR for mortality ≤30 days was WHF 31.77 (95% CI 7.60-132.81), MI 154.77 (95% CI 34.21-700.17), and stroke 223.30 (95% CI 51.42-969.78); for >30 days it was WHF 3.36 (95% CI 2.79-4.05), MI 3.29 (95% CI 2.14-5.06), and stroke 5.13 (95% CI 3.61-7.29).
Conclusions: In patients with both HF-REF and HF-PEF, hospitalization for WHF was associated with high early and late mortality. The early relative risk of death was not as great as following MI or stroke, but the longer term relative risk of death was similar following all three types of event. Numerically, more deaths occurred following WHF because it was a much more common event.
Keywords: Clinical trials; HF‐PEF; HF‐REF; Heart failure; Mortality.
© 2014 The Authors. European Journal of Heart Failure © 2014 European Society of Cardiology.
Similar articles
-
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.Circulation. 2015 Jan 6;131(1):43-53. doi: 10.1161/CIRCULATIONAHA.114.012284. Epub 2014 Nov 18. Circulation. 2015. PMID: 25406306 Clinical Trial.
-
Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme.Eur J Heart Fail. 2015 Feb;17(2):196-204. doi: 10.1002/ejhf.221. Eur J Heart Fail. 2015. PMID: 25678097 Clinical Trial.
-
Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study.Eur J Heart Fail. 2014 Dec;16(12):1362-71. doi: 10.1002/ejhf.186. Epub 2014 Nov 5. Eur J Heart Fail. 2014. PMID: 25371147 Clinical Trial.
-
Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.J Cardiovasc Med (Hagerstown). 2015 Sep;16(9):583-90. doi: 10.2459/JCM.0000000000000100. J Cardiovasc Med (Hagerstown). 2015. PMID: 25022929 Review.
-
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.Eur Heart J. 2012 Jul;33(14):1750-7. doi: 10.1093/eurheartj/ehr254. Epub 2011 Aug 6. Eur Heart J. 2012. PMID: 21821849 Review.
Cited by
-
Heart rate-corrected systolic ejection time: population-based reference values and differential prognostic utility in acute heart failure.Eur Heart J Imaging Methods Pract. 2023 Sep 12;1(2):qyad020. doi: 10.1093/ehjimp/qyad020. eCollection 2023 Sep. Eur Heart J Imaging Methods Pract. 2023. PMID: 39045077 Free PMC article.
-
Pharmacological interventions for heart failure in people with chronic kidney disease.Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD012466. doi: 10.1002/14651858.CD012466.pub2. Cochrane Database Syst Rev. 2020. PMID: 32103487 Free PMC article.
-
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.Cochrane Database Syst Rev. 2021 May 22;5(5):CD012721. doi: 10.1002/14651858.CD012721.pub3. Cochrane Database Syst Rev. 2021. PMID: 34022072 Free PMC article.
-
Identification of urgent gaps in public and policymaker knowledge of heart failure: Results of a global survey.BMC Public Health. 2023 May 30;23(1):1023. doi: 10.1186/s12889-023-15405-4. BMC Public Health. 2023. PMID: 37254075 Free PMC article.
-
Mortality from Heart Failure with Mid-Range Ejection Fraction.Arq Bras Cardiol. 2022 Apr;118(4):694-700. doi: 10.36660/abc.20210050. Arq Bras Cardiol. 2022. PMID: 35508046 Free PMC article. English, Portuguese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous